SCHEMBL3168698

SCHEMBL3168698

CCn1cnc2c(=O)n(-c3ccc(C)nc3)c(C3CCC(C(F)(F)F)CC3)nc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 2/20 0.38
CNR2 P34972 1/20 0.33
PDE4B Q07343 2/20 0.32
PDE4A P27815 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
ELANE P08246 1/20 0.32
DRD1 P21728 3/20 0.32
DRD5 P21918 3/20 0.32
PDE1A P54750 1/20 0.31
PDE1B Q01064 1/20 0.31
PDE1C Q14123 1/20 0.31
YTHDC1 Q96MU7 1/20 0.31
CDK1 P06493 3/20 0.31
CCNB1 P14635 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
ABL1 P00519 1/20 0.31
SRC P12931 1/20 0.31
ADORA3 P0DMS8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3168689 1.00 MAT2A (0.38) MAT2ACNR2PDE4BPDE4APDE4C
SCHEMBL3169414 0.90 YTHDC1 (0.35) CNR2PDE4BPDE4APDE4CPDE4D
SCHEMBL3169408 0.90 YTHDC1 (0.35) CNR2PDE4BPDE4APDE4CPDE4D
SCHEMBL3177139 0.87 CDK1 (0.38) CNR2PDE4BPDE4APDE4CPDE4D
SCHEMBL3177134 0.87 CDK1 (0.38) CNR2PDE4BPDE4APDE4CPDE4D
SCHEMBL3182650 0.87 CTSS (0.35) PDE4BPDE4DPDE1APDE1BPDE1C
SCHEMBL3182660 0.87 CTSS (0.35) PDE4BPDE4DPDE1APDE1BPDE1C
SCHEMBL3176808 0.87 DRD1 (0.41) CNR2PDE4BPDE4APDE4CPDE4D
SCHEMBL3174616 0.85 CTSS (0.37) PDE4BPDE4APDE4CPDE4DDRD1
SCHEMBL3174620 0.85 CTSS (0.37) PDE4BPDE4APDE4CPDE4DDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100008866-A1 CIS-CYCLOHEXYL SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2010-01-14 US claimed
US-20100008866-A1 CIS-CYCLOHEXYL SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100008866-A1 CIS-CYCLOHEXYL SUBSTITUTED PYRIMIDINONE DERIVATIVES PIGS, GPR174, GPR17 MAT2A 1408/4885CNR2 18/4885PDE4B 1345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.